XML 100 R87.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Net sales $ 698,144 $ 550,846
Total costs of sales 552,721 443,644
Gross profit 145,423 107,202
Selling, general and administrative expense 128,506 115,648
Acquisition, restructuring and integration expense 8,835 22,355
Impairment charges   82,083
Loss on disposal of property, plant and equipment 243 7,750
Total operating expenses 137,584 227,836
Income from operations 7,839 (120,634)
Other (income) expense, net (34) 547
Interest expense 32,549 25,229
Loss before income taxes (24,676) (146,410)
Income tax benefit (3,368) (17,545)
Net loss [1] (21,308) (128,865)
Net income attributable to noncontrolling interest 639 306
Net loss attributable to shareholders (21,947) (129,171)
Accumulating preferred dividends (24,208) (18,513)
Net loss attributable to common shareholders $ (46,155) $ (147,684)
(Loss) earnings per common share:    
Basic (in dollars per unit) [1] $ (1.34) $ (4.32)
Diluted (in dollars per unit) [1] $ (1.34) $ (4.32)
Weighted-average number of shares outstanding    
Basic (in units) [1] 34,472 34,202
Diluted (in units) [1] 34,472 34,202
Product    
Net sales $ 551,013 $ 424,906
Total costs of sales 423,314 330,310
Forward contract and other    
Net sales 147,131 125,940
Total costs of sales $ 129,407 $ 113,334
[1] Retroactively restated for de-SPAC merger transaction as described in Note 2.